Finance

Lists
688363:SHA
Bloomage Biotechnology Corp Ltd
CNÂ¥33.60
+0.90%
(+0.30) 1D
Oct 16, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688363...
Open
CNÂ¥33.60
High
CNÂ¥34.22
Low
CNÂ¥33.31
Mkt. cap
16.04B
Avg. vol.
2.21M
Volume
2.42M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 13, 2026
P/E ratio
72.14
52-wk high
CNÂ¥56.03
52-wk low
CNÂ¥32.92
EPS
CNÂ¥0.47
No. of employees
4K
Open
CNÂ¥33.60
High
CNÂ¥34.22
Low
CNÂ¥33.31
Mkt. cap
16.04B
Avg. vol.
2.21M
Volume
2.42M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 13, 2026
P/E ratio
72.14
52-wk high
CNÂ¥56.03
52-wk low
CNÂ¥32.92
EPS
CNÂ¥0.47
No. of employees
4K
News stories
From web sources and news partners
About Bloomage Biotechnology Corp Ltd
CEO-
Employees3.66K
FoundedJan 3, 2000
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
902.71M
1.04B
829.41M
926.77M
Cost of goods sold
229.76M
424.91M
266.76M
309.76M
Cost of revenue
229.76M
424.91M
266.76M
309.76M
Research and development expenses
130.12M
110.93M
85.79M
126.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
453.58M
518.96M
381.27M
441.66M
Operating expense
535.30M
708.90M
472.76M
589.44M
Total operating expenses
765.07M
1.13B
739.52M
899.20M
Operating income
137.64M
-98.12M
89.88M
27.57M
Other non operating income
11.27M
-7.86M
-16.12M
15.83M
EBT including unusual items
31.21M
42.27M
68.02M
84.06M
EBT excluding unusual items
134.90M
-101.61M
73.54M
51.15M
Income tax expense
-310.64K
3.44M
3.01M
-4.10M
Effective tax rate
-1.00%
8.15%
4.43%
-4.87%
Other operating expenses
-66.17M
82.75M
-5.33M
25.13M
Net income
31.53M
39.68M
64.65M
88.13M
Net profit margin
3.49%
3.83%
7.80%
9.51%
Earnings per share
-
-
-
-
Interest and investment income
1.81M
2.07M
2.19M
25.59M
Interest expense
-1.38M
-2.93M
-2.41M
-2.44M
Net interest expenses
433.84K
-859.53K
-228.42K
23.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
195.92M
-22.51M
165.50M
111.40M
Gain or loss from assets sale
-445.46K
-217.33K
-
-594.41K
AI content may include mistakes. Learn more
Google apps